Actively Recruiting

Age: 18Years +
All Genders
NCT06311123

Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis

Led by University of California, San Diego · Updated on 2024-03-15

10

Participants Needed

1

Research Sites

155 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to learn about the mechanism of action of ozanimod in patients with ulcerative colitis (UC). The main questions it aims to answer are: 1. Prospectively assess the effects of ozanimod on the cellular composition of intestinal lamina propria and blood by deep immunophenotyping (CyTOF) of immune cell subsets prior and after the drug's administration. 2. Determine whether changes in cell subsets observed via mass cytometry correlate with with clinical or histologic parameters of disease activity. Colonic biopsies and peripheral blood samples will be collected from patients with UC before and after the onset of ozanimod. Researchers will compare intestinal and peripheral leukocytes before and after the drug's administration.

CONDITIONS

Official Title

Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female patients aged 18 or older
  • Diagnosed with ulcerative colitis at least 3 months prior, confirmed by endoscopic and histologic evidence
  • Have active ulcerative colitis confirmed by endoscopy
  • Able to provide written informed consent to the IBD biobank at UCSD
  • Considered for ozanimod therapy without concurrent biologic treatments
Not Eligible

You will not qualify if you...

  • Severe inflammatory bowel disease likely requiring colectomy or ileostomy within 12 weeks as judged by physician
  • Current signs of fulminant colitis, toxic megacolon, or bowel perforation
  • Previous total colectomy
  • Platelet count below 100,000 per microliter
  • Positive stool test for pathogens or Clostridium difficile at screening (may be treated and retested if positive)
  • Prisoners or subjects involuntarily detained

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of California San Diego

San Diego, California, United States, 92093-006

Actively Recruiting

Loading map...

Research Team

J

Jesus Rivera-Nieves, MD

CONTACT

A

Alyssa Blair

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here